Literature DB >> 14992445

Clostridium difficile colitis in children with cystic fibrosis.

Sunny Zaheed Hussain1, Cathy Chu, David P Greenberg, David Orenstein, Seema Khan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14992445     DOI： 10.1023/b:ddas.0000011612.74033.78

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  47 in total

Review 1.  Recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; C P Kelly
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.

Authors:  S Schmitt-Grohé; E Wiggert; J Steffan; R Handke; S Zielen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-02       Impact factor: 2.839

3.  Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis.

Authors:  S L Peach; S P Borriello; H Gaya; F E Barclay; A R Welch
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

4.  Pseudomembranous colitis: CT evaluation of 26 cases.

Authors:  E K Fishman; M Kavuru; B Jones; J E Kuhlman; D S Merine; K D Lillimoe; S S Siegelman
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

5.  Treatment of Clostridium difficile colitis.

Authors:  J G Bartlett
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

6.  Pseudomembranous colitis after treatment with metronidazole.

Authors:  G Thomson; A H Clark; K Hare; W G Spilg
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

7.  Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis.

Authors:  T C Wu; V P McCarthy; V J Gill
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

8.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Clostridium difficile in patients with cystic fibrosis.

Authors:  C J Welkon; S S Long; C M Thompson; P H Gilligan
Journal:  Am J Dis Child       Date:  1985-08

10.  Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease.

Authors:  S Meyers; L Mayer; E Bottone; E Desmond; H D Janowitz
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682
View more
  3 in total

1.  Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings.

Authors:  Gwen Duytschaever; Geert Huys; Maarten Bekaert; Linda Boulanger; Kris De Boeck; Peter Vandamme
Journal:  Appl Environ Microbiol       Date:  2011-09-16       Impact factor: 4.792

Review 2.  The impact of Clostridium difficile on paediatric surgical practice: a systematic review.

Authors:  D Mc Laughlin; F Friedmacher; P Puri
Journal:  Pediatr Surg Int       Date:  2014-07-10       Impact factor: 1.827

3.  Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.

Authors:  Maiara Brusco de Freitas; Emilia Addison Machado Moreira; Camila Tomio; Yara Maria Franco Moreno; Felipe Perozzo Daltoe; Eliana Barbosa; Norberto Ludwig Neto; Vittoria Buccigrossi; Alfredo Guarino
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.